Our Blog Melanoma360

Featured image for ““A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation”
02/05/2021

“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation

Contact: Chris Miller      (972) 788-2599 Publicity         cjmiller@rainmakeradv.com (RICHARDSON, TEXAS) How do we honor the meaning of friendship and the potential…
Blog - Melanoma360
, 
Friends, Family, & Caregivers
, 
Philanthropy
Featured image for “Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor”
02/05/2021

Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor

A Partner Through It All By Mara Klecker Mark Lewis was less than a year into his relationship when he…
Blog - Melanoma360
, 
Survivor Stories
Featured image for “Art Exhibit to Honor a Friendship and Raise Funds for AIM”
02/05/2021

Art Exhibit to Honor a Friendship and Raise Funds for AIM

By Mara Klecker Melanie Brannan has had difficulty falling asleep in recent weeks. Throughout the day and into the night,…
Blog - Melanoma360
, 
Friends, Family, & Caregivers
, 
Philanthropy
Featured image for “FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma”
01/26/2021

FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma

  January 24, 2021 19:07 ET | Source: Junshi Biosciences   Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses”
01/10/2021

In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

  By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
Blog - Melanoma360
, 
In Plain English
Featured image for “President’s Letter | January 2021”
01/08/2021

President’s Letter | January 2021

From the Desk of Samantha Guild In a January newsletter it is traditional to wish you a happy new year…
Blog - Melanoma360
, 
President's Letter
Featured image for “Why Is the Tissue Bank So Important For Melanoma Research?”
01/08/2021

Why Is the Tissue Bank So Important For Melanoma Research?

  We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment;…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “What is Oral Parity, and Why Does it Matter?”
01/08/2021

What is Oral Parity, and Why Does it Matter?

  We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients”
01/08/2021

AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients

by Mara Klecker Amid the COVID-19 pandemic, AIM at Melanoma has redoubled its efforts to meet the needs of melanoma…
Blog - Melanoma360
Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
02/05/2021

“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation

Contact: Chris Miller      (972) 788-2599 Publicity         cjmiller@rainmakeradv.com (RICHARDSON, TEXAS) How do we honor the meaning of friendship and the potential…
Featured image for ““A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
02/05/2021

Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor

A Partner Through It All By Mara Klecker Mark Lewis was less than a year into his relationship when he…
Featured image for “Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor”
Blog - Melanoma360
 | 
Survivor Stories
02/05/2021

Art Exhibit to Honor a Friendship and Raise Funds for AIM

By Mara Klecker Melanie Brannan has had difficulty falling asleep in recent weeks. Throughout the day and into the night,…
Featured image for “Art Exhibit to Honor a Friendship and Raise Funds for AIM”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
01/26/2021

FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma

  January 24, 2021 19:07 ET | Source: Junshi Biosciences   Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
Featured image for “FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
01/10/2021

In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses

  By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
Featured image for “In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses”
Blog - Melanoma360
 | 
In Plain English
01/08/2021

President’s Letter | January 2021

From the Desk of Samantha Guild In a January newsletter it is traditional to wish you a happy new year…
Featured image for “President’s Letter | January 2021”
Blog - Melanoma360
 | 
President's Letter
01/08/2021

Why Is the Tissue Bank So Important For Melanoma Research?

  We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment;…
Featured image for “Why Is the Tissue Bank So Important For Melanoma Research?”
Blog - Melanoma360
 | 
Melanoma Research
01/08/2021

What is Oral Parity, and Why Does it Matter?

  We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
Featured image for “What is Oral Parity, and Why Does it Matter?”
Blog - Melanoma360
 | 
Melanoma Research
01/08/2021

AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients

by Mara Klecker Amid the COVID-19 pandemic, AIM at Melanoma has redoubled its efforts to meet the needs of melanoma…
Featured image for “AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients”
Blog - Melanoma360
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research

Recent Posts

Featured image for “Cancer is More Than a Diagnosis: Mind, Meaning, and Healing”
Mar. 03, 2026

Cancer is More Than a Diagnosis: Mind, Meaning, and Healing

Featured image for “Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN® ”
Feb. 19, 2026

Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN® 

Featured image for “Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma”
Feb. 05, 2026

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

Featured image for “Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up”
Jan. 23, 2026

Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up

Featured image for “Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026”
Jan. 21, 2026

Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026

Filter by Tag